Spironolactone inhibits the NLRP1 inflammasome and alleviates defective erythropoiesis in Diamond-Blackfan anemia. [PDF]
Rodríguez-Ruiz L +15 more
europepmc +1 more source
Eplerenone, a mineralocorticoid receptor inhibitor, reduces cirrhosis associated changes of hepatocyte glucose and lipid metabolism. [PDF]
Mohib MM +7 more
europepmc +1 more source
Efficacy and safety of mineralocorticoid receptor antagonists in kidney transplant patients: an updated meta-analysis of randomized controlled trials. [PDF]
Dibo P +6 more
europepmc +1 more source
Authors' Response: Possible dose-dependent effect of eplerenone on intraocular pressure
Seyedeh Mehrsa Sadat Razavi +1 more
openalex +1 more source
Aldosterone-Related Cardiovascular Disease and Benefits of Mineralocorticoid Receptor Antagonists in Clinical Practice. [PDF]
Alfarano M +10 more
europepmc +1 more source
Medical Therapy for Heart Failure After Mitral Valve Transcatheter Repair: One Size Does Not Fit All. [PDF]
Mazzola M, Giannini C.
europepmc +1 more source
Mineralocorticoid Receptor Antagonism with Finerenone: A New Era in the Management of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction. [PDF]
Georgianos PI +6 more
europepmc +1 more source
Efficacy of Topical Non-Selective and COX-2 Selective NSAIDs in Accelerating Resolution of Acute Central Serous Chorioretinopathy: A Retrospective Analysis. [PDF]
O'Brien P +8 more
europepmc +1 more source
パーシャルアゴニスト カッセイ ヲ ユウスル シンキ MR キッコウヤク ノ ヤクリ サヨウ ニカンスル ケンキュウ コウカリウム ケッショウ リスク テイゲンカ ニ チャクモク シタ シンキ チリョウ センリャク [PDF]
ナリアイ, テツロウ +1 more
core
Mineralocorticoid receptor antagonists promote renal immunosenescence. [PDF]
Wang QR, Yang Y.
europepmc +1 more source

